ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
CONMED Corporation

CONMED Corporation (CNMD)

67.95
0.60
(0.89%)
Closed January 05 4:00PM
67.95
0.00
(0.00%)
After Hours: 5:30PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
67.95
Bid
-
Ask
-
Volume
286,662
65.835 Day's Range 68.22
61.05 52 Week Range 113.675
Market Cap
Previous Close
67.35
Open
67.625
Last Trade
38708
@
67.95
Last Trade Time
Financial Volume
$ 19,221,670
VWAP
67.0534
Average Volume (3m)
409,977
Shares Outstanding
30,890,853
Dividend Yield
1.18%
PE Ratio
48.60
Earnings Per Share (EPS)
2.09
Revenue
1.24B
Net Profit
64.46M

About CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. ce... Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
CONMED Corporation is listed in the Electromedical Apparatus sector of the New York Stock Exchange with ticker CNMD. The last closing price for CONMED was $67.35. Over the last year, CONMED shares have traded in a share price range of $ 61.05 to $ 113.675.

CONMED currently has 30,890,853 shares outstanding. The market capitalization of CONMED is $2.08 billion. CONMED has a price to earnings ratio (PE ratio) of 48.60.

CNMD Latest News

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

  CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will...

CONMED Corporation Announces Quarterly Cash Dividend

CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all...

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.48-3.5212267499670.4371.266.7727909968.83340717CS
4-5.07-6.943303204673.0276.3466.7740669770.60720638CS
126.069.7915656810561.897861.6540997770.42511492CS
260.450.66666666666767.578.1961.446241853570.12560097CS
52-40.91-37.5803784678108.86113.67561.0547618875.59155526CS
156-73.94-52.1107900486141.89156.2461.0540849794.7618415CS
260-32.19-32.1449970042100.14159.1137.6636535196.70765356CS

CNMD - Frequently Asked Questions (FAQ)

What is the current CONMED share price?
The current share price of CONMED is $ 67.95
How many CONMED shares are in issue?
CONMED has 30,890,853 shares in issue
What is the market cap of CONMED?
The market capitalisation of CONMED is USD 2.08B
What is the 1 year trading range for CONMED share price?
CONMED has traded in the range of $ 61.05 to $ 113.675 during the past year
What is the PE ratio of CONMED?
The price to earnings ratio of CONMED is 48.6
What is the cash to sales ratio of CONMED?
The cash to sales ratio of CONMED is 2.52
What is the reporting currency for CONMED?
CONMED reports financial results in USD
What is the latest annual turnover for CONMED?
The latest annual turnover of CONMED is USD 1.24B
What is the latest annual profit for CONMED?
The latest annual profit of CONMED is USD 64.46M
What is the registered address of CONMED?
The registered address for CONMED is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the CONMED website address?
The website address for CONMED is www.conmed.com
Which industry sector does CONMED operate in?
CONMED operates in the ELECTROMEDICAL APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STEMStem Inc
$ 1.20
(54.74%)
80.16M
KUKEKuke Music Holding Limited
$ 0.633
(44.55%)
3.92M
BPTBP Prudhoe Bay Royalty Trust
$ 0.7265
(30.67%)
566.4k
OKLOOklo Inc
$ 27.22
(24.58%)
23.88M
JOBYJoby Aviation Inc
$ 9.76
(20.64%)
29.08M
CCMConcord Medical Services Holdings Ltd
$ 4.50
(-30.23%)
123.26k
ALURAllurion Technologies Inc
$ 7.675
(-26.41%)
193.64k
RCSPIMCO Strategic Income Fund Inc
$ 5.74
(-24.17%)
1.93M
PCMPCM Fund Inc
$ 6.70
(-13.77%)
481.85k
PERFPerfect Corp
$ 2.56
(-12.33%)
328.84k
STEMStem Inc
$ 1.20
(54.74%)
80.16M
FFord Motor Company
$ 9.885
(2.44%)
77.2M
QBTSD Wave Quantum Inc
$ 9.135
(-4.94%)
64.68M
ACHRArcher Aviation Inc
$ 11.485
(20.01%)
55.75M
ABEVAmbev SA
$ 1.7697
(-3.30%)
52.31M

Discussion

View Full Feed
HokieHead HokieHead 4 minutes ago
Wrong..
TWOH
HokieHead HokieHead 4 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 6 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 7 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 7 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 8 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 9 minutes ago
Testimony from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed with AD depen
AVXL
CaptHowdy CaptHowdy 10 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 10 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 13 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL
facts_matter14 facts_matter14 14 minutes ago
Looks like Baggy is worried about Maxine not showing up at CES this week…………….









.
SRMX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 14 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

OK so we should see the test start this quarter then?
AVXL
Canna_Business Canna_Business 14 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
mrfence mrfence 15 minutes ago
Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
GME
Canna_Business Canna_Business 15 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
eb0783 eb0783 15 minutes ago
Thanks TJG. I never thought the subject needed any discussion......it was so obvious. Yet some feel they should denigrate the company for not saying it over and over.

Our Story
Affluence Corporation (OTC PINK:AFFU) was incorporated in 2008 and initially operated as a social net
AFFU
Canna_Business Canna_Business 16 minutes ago
$MRMD
MRMD
facts_matter14 facts_matter14 16 minutes ago
Let’s play a fantasy game and pretend there are “some” products available now.

Does this look like there are “some” products available now;

https://investorshub.advfn.com/uimage/uploads/2024/11/12/pmrdbIMG_5756.jpeg

https://investorshub.advfn.com/uimage/u
SRMX
lambchops lambchops 17 minutes ago
Do the holkie polky, turn yerself around...take a look in the mirror, that's what it's all a-bout.

Baaaaaaaaaaaaaaaaaa

LC

NFTM
NFTM
crescentmotor crescentmotor 17 minutes ago
The regulatory authorities don't care who is speaking at a conference, they just care what is submitted as part of a drug application.

Maybe but I'm not convinced of that. When drugs are being considered for regulatory approval, I am always amazed at the huge effort put for by member
AVXL
demonsmith demonsmith 18 minutes ago
So nukk was trading at 0.0012 when are new ceo took control and brought it to Nasdaq from otc you half to be crazy to split know
TWOH
CrossFireTrader CrossFireTrader 18 minutes ago
Whomever he or she is they need to do a bit of homework The Cusip did change the name did change GDVM Is no longer Global Development it is VeeMost Technologies the only thing that didn't change was the Ticker and I believe it was either the Tax Accounts along with the .GOV for bidding on Government
GDVM
ChanceVision ChanceVision 19 minutes ago
Yes, Sir! Looking good! 😉👌🏼

March is looking very promising...

$AABB
AABB
jjjjjjjj jjjjjjjj 19 minutes ago
Are we at $0.0001 yet? Minds over matter, don’t mind no matter. It was at $0.0004. I bought at 12:59pm for 40K shares at $20 with $6 commission and upped a $0.0001 to $0.0005. There is no others buy at last minute. Where is our team effect? We went thru $0.22, $0.08, $0.02, $0.01, $0.00053, $0.0004,
MJNA
JERSEYHAWG JERSEYHAWG 20 minutes ago
Well I looked up that name and saw that post. Cause that's what was sent to me.i will be damed. Its all good.

BTW, BIG mets freak here anf baseball is my game. Just for your. 2 cents. Took my wife to Boston just so we could both see Fenway park. On the coldest day of the year. For t
LEHNQ

Your Recent History

Delayed Upgrade Clock